Luke Ashton

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

National Hospital for Neurology and Neurosurgery(Current)

Merck Serono Ltd. (United Kingdom)

UCL Biomedical Research Centre

University College London

Luke Ashton is an author at National Hospital for Neurology and Neurosurgery specializing in relapsing-remitting multiple sclerosis treatment, outcomes research, and treatment completion assessment.

Publications per year

2023–2023

Publications

Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study

Wallace Brownlee, Amerah Amin, Luke Ashton et al. · Multiple Sclerosis and Related Disorders · 2023 · 19 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study

David Rog, Wallace Brownlee, Francisco Javier Carod-Artal et al. · Multiple Sclerosis and Related Disorders · 2023 · 12 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

1–2 of 2